Analysts Predict a Shift in DENTSPLY SIRONA's Narrative Due to Revised Targets and Emerging Risks
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 23 2025
0mins
Source: Yahoo Finance
Fair Value Estimate Decline: DENTSPLY SIRONA's fair value estimate has decreased from $16 to approximately $13, reflecting a higher risk premium due to operational and market challenges.
Analyst Perspectives: Analysts express mixed views, with UBS maintaining a Buy rating and a $23 price target, while others like JPMorgan and Piper Sandler have lowered their targets, citing ongoing challenges and a need for improved execution.
Leadership Changes and Financial Adjustments: The company announced the departure of CFO Matthew E. Garth and reported significant noncash impairment charges, alongside a revised earnings guidance forecasting a decline in sales.
Market Sentiment and Future Outlook: Wall Street analysts are currently cautious about DENTSPLY SIRONA's near-term prospects, emphasizing the importance of management's new strategies and execution for potential long-term recovery.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like XRAY with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
Analyst Views on XRAY
Wall Street analysts forecast XRAY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for XRAY is 13.04 USD with a low forecast of 12.00 USD and a high forecast of 17.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
16 Analyst Rating
2 Buy
13 Hold
1 Sell
Hold
Current: 12.310
Low
12.00
Averages
13.04
High
17.00
Current: 12.310
Low
12.00
Averages
13.04
High
17.00
About XRAY
DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. It develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices. Its Connected Technology Solutions segment includes design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of its value-added endodontic, restorative, and preventive consumable products and small equipment used by dental professionals for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and dental professional-directed aligner solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for urinary and bowel management.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Halper Sadeh Investigates Dentsply Sirona Executives for Breach of Fiduciary Duties
- Legal Investigation Launched: Halper Sadeh LLC is investigating whether executives of Dentsply Sirona Inc. breached their fiduciary duties to shareholders, potentially impacting corporate governance and shareholder rights.
- Shareholder Rights Protection: Long-term shareholders of Dentsply may seek corporate governance reforms, fund recovery, or court-approved financial incentives aimed at enhancing company transparency and accountability.
- Legal Fee Arrangement: The firm will handle the case on a contingency fee basis, meaning shareholders will not be responsible for legal fees, thereby reducing the financial burden of participation.
- Importance of Investor Participation: Shareholder involvement can improve company policies and oversight mechanisms, enhancing shareholder value; Halper Sadeh LLC represents investors globally in seeking compensation for securities fraud and corporate misconduct.
Continue Reading
Dentsply Sirona (XRAY) Renews Dental Tech Agreement with Patterson Dental
- Partnership Continuation: Dentsply Sirona has renewed its U.S. dental technology distribution agreement with Patterson Dental, reaffirming their long-standing collaboration aimed at driving market growth through innovation.
- Product Portfolio Assurance: The new agreement ensures Patterson Dental customers will continue to access Dentsply Sirona's full range of dental technology solutions, including CEREC systems, Primescan intraoral scanners, and imaging systems, enhancing customer service experience.
- Accelerated Technology Integration: The partnership aims to accelerate the adoption of integrated and connected dental technologies, thereby improving practice efficiency and patient care quality, pushing the industry towards digital transformation.
- Positive Market Reaction: In pre-market trading on Nasdaq, Dentsply Sirona's stock rose by 0.74% to $12.22, reflecting market optimism regarding the renewal of this partnership.
Continue Reading